Newsletters

Psychiatry Advisor

• Autism Heritability Differs Between Men and Women April 25, 2024
  Researchers conducted a population-based study to determine sex differences in autism heritability within families, using Swedish national register data. The post Autism Heritability Differs Between Men and Women appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Black Patients Are Administered More PRN Antipsychotics Than White Patients April 25, 2024
  Researchers conducted a study to evaluate potential racial disparities in the administration of both antipsychotic and non-antipsychotic PRN medications. The post Black Patients Are Administered More PRN Antipsychotics Than White Patients appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Text-Embedding Model Can Identify PTSD Following Childbirth April 25, 2024
  A text-embedding-ada-002 (ADA) machine learning model can identify posttraumatic stress disorder following childbirth (CB-PTSD) from maternal childbirth narratives. The post Text-Embedding Model Can Identify PTSD Following Childbirth appeared first on Psychiatry Advisor.
  Haymarket Media
• PCPs Provide Most of the Care Related to Life’s Essential 8 April 25, 2024
  Primary care is the dominant source of care for Life's Essential 8 (LE8), according to a research letter published online. The post PCPs Provide Most of the Care Related to Life’s Essential 8 appeared first on Psychiatry Advisor.
  Haymarket Media
• March 2024 Recap: Drug Pipeline Updates April 25, 2024
  The table below is a review of notable updates that occurred in March 2024 for investigational products in development. The post March 2024 Recap: Drug Pipeline Updates appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Tirzepatide Improves Sleep Apnea Symptoms in Obese Patients With OSA April 25, 2024
  The double-blind, phase 3 study included 2 groups of patients, those who were not on positive airway pressure therapy and those who were. The post Tirzepatide Improves Sleep Apnea Symptoms in Obese Patients With OSA appeared first on Psychiatry Advisor.
  Diana Ernst, RPh
• Lumateperone Effective as Adjunctive Therapy for Major Depressive Disorder April 25, 2024
  The phase 3 study evaluated the efficacy and safety of lumateperone as an adjunctive treatment to antidepressants in 485 patients with MDD. The post Lumateperone Effective as Adjunctive Therapy for Major Depressive Disorder appeared first on Psychiatry Advisor.
  Steve Duffy
• Can Exposure to Airborne Metals Increase Parkinson Disease Risk? April 25, 2024
  In a population-based, case-control study, researchers assessed the relationship between environmental exposure to airborne metals and Parkinson disease risk. The post Can Exposure to Airborne Metals Increase Parkinson Disease Risk? appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• ADHD Medications Associated With Reduced Risk for Suicidality, Hospitalizations April 24, 2024
  Researchers used Swedish national register data to evaluate the effect of ADHD medication use on work disability and mental health outcomes. The post ADHD Medications Associated With Reduced Risk for Suicidality, Hospitalizations appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• In-Person Schooling Aids Pediatric Mental Health for Urban, Minoritized Children April 24, 2024
  Researchers conducted a longitudinal study to examine pediatric mental health among urban, minoritized children during the first 2 years of the pandemic. The post In-Person Schooling Aids Pediatric Mental Health for Urban, Minoritized Children appeared first on Psychiatry Advisor.
  Meahjabeen Hoque